The G972R variant of the insulin receptor substrate-1 (IRS-1) gene is associated with insulin resistance in “uncomplicated” obese subjects evaluated by hyperinsulinemic-euglycemic clamp

[1]  G. Pellegrini,et al.  G972R IRS-1 Variant Impairs Insulin Regulation of Endothelial Nitric Oxide Synthase in Cultured Human Endothelial Cells , 2004, Circulation.

[2]  M. McCarthy,et al.  Insulin receptor substrate-1 gene mutations in NIDDM; implications for the study of polygenic disease , 1995, Diabetologia.

[3]  G. Sesti,et al.  The Arg972 variant in insulin receptor substrate-1 is associated with an atherogenic profile in offspring of type 2 diabetic patients. , 2003, The Journal of clinical endocrinology and metabolism.

[4]  E. Feskens,et al.  Gly972Arg variant in the insulin receptor substrate-1 gene and association with Type 2 diabetes: a meta-analysis of 27 studies , 2003, Diabetologia.

[5]  S. Le Fur,et al.  Increased insulin resistance in obese children who have both 972 IRS-1 and 1057 IRS-2 polymorphisms. , 2002, Diabetes.

[6]  M. White,et al.  Molecular insights into insulin action and secretion , 2002, European journal of clinical investigation.

[7]  G. Nijpels,et al.  Variations in insulin secretion in carriers of gene variants in IRS-1 and -2. , 2002, Diabetes.

[8]  M. Stumvoll,et al.  The Gly972Arg polymorphism in the insulin receptor substrate-1 gene contributes to the variation in insulin secretion in normal glucose-tolerant humans. , 2001, Diabetes.

[9]  M. Arca,et al.  The G972R variant of the Insulin Receptor Substrate-1 (IRS-1) gene, body fat distribution and insulin-resistance , 2001, Diabetologia.

[10]  L. Groop,et al.  Determinants of postabsorptive endogenous glucose output in non-diabetic subjects , 2000, Diabetologia.

[11]  D. Accili,et al.  The Gly-->Arg972 amino acid polymorphism in insulin receptor substrate-1 affects glucose metabolism in skeletal muscle cells. , 2000, The Journal of clinical endocrinology and metabolism.

[12]  M. Stumvoll,et al.  Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. , 2000, Diabetes care.

[13]  H. Häring,et al.  Amino acid polymorphism Gly 972 Arg in IRS-1 is not associated to lower clamp-derived insulin sensitivity in young healthy first degree relatives of patients with type 2 diabetes. , 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[14]  A. Montali,et al.  A common mutation of the insulin receptor substrate-1 gene is a risk factor for coronary artery disease. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[15]  K. Tsuchihashi,et al.  Insulin Sensitivity Is Not Affected by Mutation of Codon 972 of the Human IRS-1 Gene , 1999, Hormone Research in Paediatrics.

[16]  D. Accili,et al.  The Gly972-->Arg amino acid polymorphism in IRS-1 impairs insulin secretion in pancreatic beta cells. , 1999, The Journal of clinical investigation.

[17]  M. Matsuda,et al.  Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. , 1999, Diabetes care.

[18]  A. Koyanagi,et al.  Codon 972 Polymorphism of the Insulin Receptor Substrate-1 Gene in Impaired Glucose Tolerance and Late-Onset NIDDM , 1998, Diabetes Care.

[19]  M. Makuuchi,et al.  Hypertension, hypertriglyceridemia, and impaired endothelium-dependent vascular relaxation in mice lacking insulin receptor substrate-1. , 1998, The Journal of clinical investigation.

[20]  Kirk M. Ririe,et al.  Product differentiation by analysis of DNA melting curves during the polymerase chain reaction. , 1997, Analytical biochemistry.

[21]  U J Balis,et al.  The LightCycler: a microvolume multisample fluorimeter with rapid temperature control. , 1997, BioTechniques.

[22]  L. Groop,et al.  UKPDS 19: Heterogeneity in NIDDM: separate contributions of IRS-1 and b3-adrenergic-receptor mutations to insulin resistance and obesity respectively with no evidence for glycogen synthase gene mutations , 1996, Diabetologia.

[23]  O. Pedersen,et al.  A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signaling. Evidence from transfection studies. , 1996, The Journal of clinical investigation.

[24]  R. Holman,et al.  U.K. Prospective Diabetes Study , 1996, Diabetes Care.

[25]  T. Hansen,et al.  Insulin resistance: interactions between obesity and a common variant of insulin receptor substrate-1 , 1995, The Lancet.

[26]  D. Accili,et al.  Variant sequences of insulin receptor substrate-1 in patients with noninsulin-dependent diabetes mellitus. , 1994, The Journal of clinical endocrinology and metabolism.

[27]  R. DeFronzo,et al.  Glucose clamp technique: a method for quantifying insulin secretion and resistance. , 1979, The American journal of physiology.